Pathology of Experimental Machupo Virus Infection, Chicava Strain, in Cynomolgus Macaques (Macaca fascicularis) by Intramuscular and Aerosol Exposure

Veterinary Pathology

Volumn 52, Issue 1, 2015, Pages 26-37

  Bell, T M ^a   Shaia, C I ^b   Bunton, T E ^c   Robinson, C G ^a   Wilkinson, E R ^a   Hensley, L E ^d   Cashman, K A ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b JOINT PATHOLOGY CENTER   (United States)

^c Eicarte LLC   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

aerosols; American; animal; arenaviruses; Bolivia; hemorrhagic fever; Macaca fascicularis; Machupo virus; models; New World

Indexed keywords

AEROSOL;

ADMINISTRATION AND DOSAGE; ADRENAL GLAND; AEROSOL; AMERICAN HEMORRHAGIC FEVER; ANIMAL; DISEASE MODEL; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER; LUNG; LYMPH NODE; MACACA FASCICULARIS; MALE; NEW WORLD ARENAVIRUS; PATHOLOGY; PHYSIOLOGY; SPLEEN; VIROLOGY;

ADRENAL GLANDS; AEROSOLS; ANIMALS; ARENAVIRUSES, NEW WORLD; DISEASE MODELS, ANIMAL; FEMALE; HEMORRHAGIC FEVER, AMERICAN; HUMANS; INJECTIONS, INTRAMUSCULAR; LIVER; LUNG; LYMPH NODES; MACACA FASCICULARIS; MALE; SPLEEN;

EID: 84920054137     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985814540544     Document Type: Article

References (42)

1. Alibek K,Handelman SBiohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World. New York, NY: Random House; 1999:
2. Angelov GS,Guillaume P,Luescher IF.CD8beta knockout mice mount normal anti-viral CD8+ T cell responses—but why?.Int Immunol. 2009;21 ((2)): 123-135
3. Bray M.Pathogenesis of viral hemorrhagic fever.Curr Opin Immunol. 2005;17 ((4)): 399-403
4. Bolivian hemorrhagic fever—El Beni Department, Bolivia, 1994.MMWR Morb Mortal Wkly Rep. 1994;43 ((50)): 943-946
5. Charrel RN,de Lamballerie X.Arenaviruses other than Lassa virus.Antiviral Res. 2003;57 ((1–2)): 89-100
6. Child PL,Mackenzie RB,Valverde LR, et al.Bolivian hemorrhagic fever: a pathologic description.Arch Pathol. 1967;83 ((5)): 434-445
7. Dabisch PA,Kline J,Lewis C, et al.Characterization of a head-only aerosol exposure system for nonhuman primates.Inhal Toxicol. 2010;22 (3): 224-233
8. Department of Health and Human Services, National Institutes of Health. National Institute of Allergy and Infectious Disease Category A, B, and C Priority Pathogens. Biodefense and Emerging Infectious Diseases. 2012. http://www.niaid.nih.gov/topics/biodefenserelated/biodefense/pages/cata.aspx. Accessed April 1, 2013.
9. Eddy GA,Scott SK,Wagner FS, et al.Pathogenesis of Machupo virus infection in primates.Bull World Health Organ. 1975;52 ((4–6)): 517-521
10. Food and Drug Administration. 21 Code of Federal Regulations, part 314.610. Approval based on evidence of effectiveness from studies in animals. 2013. http://www.gpo.gov/fdsys/pkg/CFR-2013-title21-vol5/pdf/CFR-2013-title21-vol5-sec314-610.pdf. Accessed January 29, 2014.
11. Gardner MB,Luciw PA.Macaque models of human infectious disease.ILAR J. 2008;49 ((2)): 220-255
12. Garrett LThe Coming Plague: Newly Emerging Diseases in a World Out of Balance. New York, NY: Farrar, Straus, and Giroux; 1994:
13. Geisbert TW,Hensley LE.Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions.Expert Rev Mol Med. 2004;6 ((20)): 1-24
14. Geisbert TW,Hensley LE,Gibb TR, et al.Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses.Lab Invest. 2000;80 ((2)): 171-186
15. Geisbert TW,Hensley LE,Larsen T, et al.Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.Am J Pathol. 2003;163 ((6)): 2347-2370
16. Gowen BB,Smee DF,Wong MH, et al.Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin.PLoS One. 2008;3 ((11)): e3725
17. Hartings JM,Roy CJ.The automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates.J Pharmacol Toxicol Methods. 2004;49 (1): 39-55
18. Hooper JW,Kamrud KI,Elgh F, et al.DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against Seoul virus infection.Virology. 1999;255 ((2)): 269-278
19. Howard CRArenaviruses. Amsterdam, NL: Elsevier Science Publishers BV; 1986:
20. Jahrling PB,Marty AM,Geisbert TMMedical Aspects of Biological Warfare. Dembek ZF, ed. Washington, DC: Borden Institute; 2007:271-310.
21. Johnson KM.Epidemiology of Machupo virus infection: 3. Significance of virological observations in man and animals.Am J Trop Med Hyg. 1965;14 ((5)): 816-818
22. Johnson KM,Kuns ML,Mackenzie RB, et al.Isolation of Machupo virus from wild rodent Calomys callosus.Am J Trop Med Hyg. 1966;15 ((1)): 103-106
23. Johnson KM,Mackenzie RB,Webb PA, et al.Chronic infection of rodents by Machupo virus.Science. 1965;150 ((3703)): 1618-1619
24. Johnson KM,Wiebenga NH,Mackenzie RB, et al.Virus isolations from human cases of hemorrhagic fever in Bolivia.Proc Soc Exp Biol Med. 1965;118:113-118
25. Kastello MD,Eddy GA,Kuehne RW.A rhesus monkey model for the study of Bolivian hemorrhagic fever.J Infect Dis. 1976;133 ((1)): 57-62
26. Kilgore PE,Ksiazek TG,Rollin PE, et al.Treatment of Bolivian hemorrhagic fever with intravenous ribavirin.Clin Infect Dis. 1997;24 ((4)): 718-722
27. Kuns ML.Epidemiology of Machupo virus infection: II. Ecological and control studies of hemorrhagic fever.Am J Trop Med Hyg. 1965;14 ((5)): 813-816
28. Mackenzie RB.Epidemiology of Machupo virus infection: I. Pattern of human infection, San Joaquin, Bolivia, 1962–1964.Am J Trop Med Hyg. 1965;14 ((5)): 808-813
29. Mackenzie RB,Beye HK,Valverde L, et al.Epidemic hemorrhagic fever in Bolivia: I. A preliminary report of the epidemiologic and clinical findings in a new epidemic area in South America.Am J Trop Med Hyg. 1964;13:620-625
30. McLeod CG,Stookey JL,Eddy GA, et al.Pathology of chronic Bolivian hemorrhagic fever in the rhesus monkey.Am J Pathol. 1976;84 ((2)): 211-224
31. Murphy FA,Whitfield SG.Morphology and morphogenesis of arenaviruses.Bull World Health Organ. 1975;52 ((4–6)): 409-419
32. Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention. CDC Select Agent Program. http://www.cdc.gov/phpr/documents/DSAT_brochure_July2011.pdf. Updated November 17, 2008. Accessed November 18, 2013.
33. Peters CJ,Kuehne RW,Mercado RR, et al.Hemorrhagic fever in Cochabamba, Bolivia, 1971.Am J Epidemiol. 1974;99 ((6)): 425-433
34. Qian ZM,Li H,Sun H, et al.Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway.Pharmacol Rev. 2002;54 ((4)): 561-587
35. Radoshitzky SR,Kuhn JH,de Kok-Mercado F, et al.Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses.Expert Opin Drug Discov. 2012;7 ((7)): 613-632
36. Radoshitzky SR,Longobardi LE,Kuhn JH, et al.Machupo virus glycoprotein determinants for human transferrin receptor 1 binding and cell entry.PLoS One. 2011;6 ((7)): e21398
37. Roy CJ,Reed DS,Hutt JA.Aerobiology and inhalation exposure to biological select agents and toxins.Vet Pathol. 2010;47 (5): 779-789
38. Snoy PJ.Establishing efficacy of human products using animals: the US Food and Drug Administration’s “animal rule.”.Vet Pathol. 2010;47 ((5)): 774-778
39. Stinebaugh BJ,Schloeder FX,Johnson KM, et al.Bolivian hemorrhagic fever: a report of four cases.Am J Med. 1966;40 ((2)): 217-230
40. Terrell TG,Stookey JL,Eddy GA, et al.Pathology of Bolivian hemorrhagic fever in the rhesus monkey.Am J Pathol. 1973;73 ((2)): 477-494
41. Twenhafel NA,Mattix ME,Johnson JC, et al.Pathology of experimental aerosol Zaire ebolavirus infection in rhesus macaques.Vet Pathol. 2013;50 ((3)): 514-529
42. Webb PA,Justines G,Johnson KM.Infection of wild and laboratory animals with Machupo and Latino viruses.Bull World Health Organ. 1975;52 ((4–6)): 493-499